secwatch / observer
8-K filed March 13, 2024, 7:59 PM ET ticker RCMT CIK 0000700841
earnings confidence high sentiment positive materiality 0.60

RCM Technologies Q4 adjusted EBITDA $8.9M (+18.5% YoY); EPS $0.65

RCM TECHNOLOGIES, INC.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

RCM TECHNOLOGIES, INC. reported thirteen weeks ended December 30, 2023 results: revenue $71.0 million, net income $5.3 million, EPS $0.65 per diluted share.

Period
thirteen weeks ended December 30, 2023
Revenue
$71.0 million
Net income
$5.3 million
EPS
$0.65 per diluted share
Result
reported results
Exact text from the filing
RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced engineering, specialty health care, and information technology services, today announced financial results for the thirteen and fifty-two weeks ended December 30, 2023. RCM Technologies reported revenue of $71.0 million for the thirteen weeks ended December 30, 2023 (the current quarter), an increase of 1.1% compared to $70.2 million for the thirteen weeks ended December 31, 2022 (the comparable prior quarter). Gross profit was $21.6 million for the current quarter, a 5.7% increase compared to $20.5 million for the comparable prior quarter. The Company experienced GAAP operating income of $7.9 million for the current quarter compared to $6.8 million for the comparable prior quarter. The Company experienced GAAP net income of $5.3 million, or $0.65 per diluted sha
View on SEC.gov

Browse all earnings releases →

RCM TECHNOLOGIES, INC. filing history →

Source: SEC EDGAR
accession 0001437749-24-007648
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.